0      0

2022 AABB Annual Meeting

AM22-MN26-E - AM22-MN26-E: (On-Demand) Elevating Blood Collectors’ Role in Promoting Donor Health, Particularly in Underserved Communities (Enduring)


Oct 4, 2022 12:00pm ‐ Oct 4, 2022 1:00pm



Credits: None available.

Description

Blood collectors are fully committed to ensuring the health and safety of the blood donor before, during and after collection, using minimum hemoglobin requirements, blood pressure readings, detailed medical questionnaires, and other steps to this end. Some blood centers are expanding their health screening offerings to encourage donation and improve the community’s health. Examples of screening programs include offering cholesterol testing and/or diabetic screening with Hemoglobin A1C, the latter typically for a short period of time due to the high cost of testing and burdens of donor notification and communication. Donor outreach and engagement, meanwhile, is shifting from phone calls and letters to digital methods, such as secure web portals or blood donor Apps. Robust digital tools enable blood centers to provide individual donors with their health data trends, as well as educate them with greater ease and flexibility on topics like anemia, hypertension and diabetes. Blood establishments can also offer broader insights by aggregating deidentified health data to show community-wide profiles and trends, with particular attention to health trends and interventions for medically underserved communities.

Learning Objectives:
  • Assess types of donor health data being collected and how this knowledge, and concomitant educational and behavioral interventions, can be shared to benefit blood donors and drive sponsoring groups.
  • Appraise possibilities for blood collectors to bring public health services and education to low-income communities, acting in additive fashion to other community outreach channels.
  • Assess how blood centers can analyze and share biologic and safety data to promote community awareness, safety, and health

Speaker(s):

Moderator(s):

  • Dr. Pampee P. Young, MD, PhD, Chief Medical Officer, Biomedical Services, American Red Cross Biomedical Services

Disclosures

  • Pampee Young, MD, PhD : FK: Consultant CTS: Consultant Ortho Diagnostics: Speaker's Bureau Roche: Consultant
  • John Armitage, MD : Nothing to Disclose

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.